Cargando…
Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still’s disease
BACKGROUND: High-dose glucocorticoids (GC) are first-line treatment for adult-onset Still’s disease (AOSD); however, some of the patients remain refractory to initial GC therapy, or rapidly relapse. The aim of this study was to identify prognostic factors for poor treatment response to initial GC th...
Autores principales: | Kondo, Fumiaki, Sugihara, Takahiko, Umezawa, Natsuka, Hasegawa, Hisanori, Hosoya, Tadashi, Kimura, Naoki, Mori, Masaaki, Yasuda, Shinsuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052454/ https://www.ncbi.nlm.nih.gov/pubmed/35488289 http://dx.doi.org/10.1186/s13075-022-02780-3 |
Ejemplares similares
-
Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy
por: Kamiya, Mari, et al.
Publicado: (2023) -
Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides
por: Umezawa, Natsuka, et al.
Publicado: (2023) -
Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab
por: Fujiwara, Shun, et al.
Publicado: (2022) -
mCRP as a Biomarker of Adult-Onset Still’s Disease: Quantification of mCRP by ELISA
por: Fujita, Chitose, et al.
Publicado: (2022) -
Identification of Compounds With Glucocorticoid Sparing Effects on Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast-Like Synoviocytes
por: Hosoya, Tadashi, et al.
Publicado: (2020)